Evidence map›Paper›PMID 41023315›Full record

ArticleCommunications biology2025

Botulinum neurotoxin Light Chain/A1 uses fast synaptic vesicle cycling to cleave plasma membrane bound SNAP-25.

Alexander Gardner, Molly Sneller, William H Tepp, Joseph T Barbieri, Sabine Pellett

Abstract read
In one paragraph

Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alexander GardnerMicrobiology and Immunology, Medical College of Wisconsin, Milwaukee, 53226, USA.
Molly SnellerDepartment of Bacteriology, University of Wisconsin-Madison, Madison, 53706, USA.ORCID http://orcid.org/0009-0000-1357-4335
William H TeppDepartment of Bacteriology, University of Wisconsin-Madison, Madison, 53706, USA.ORCID http://orcid.org/0009-0001-2158-707X
Joseph T BarbieriMicrobiology and Immunology, Medical College of Wisconsin, Milwaukee, 53226, USA. jtb01@mcw.edu.ORCID http://orcid.org/0000-0002-9364-7465
Sabine PellettDepartment of Bacteriology, University of Wisconsin-Madison, Madison, 53706, USA. sabine.pellett@wisc.edu.ORCID http://orcid.org/0000-0001-8186-8810

Funding

Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) AI139306
6 · The paper itself

Abstract

Botulinum neurotoxins (BoNT) are the most potent protein toxins for humans, yet how BoNT-Light Chain/A1 (LC/A1) journeys to cleave intracellular SNAP-25 is understudied. Here we use a cell-based assay to measure cytosolic EGFP-LC/A1 intracellular trafficking and SNAP-25 cleavage in Neuro-2A cells. Intracellular LC/A1 associated on microtubules and co-localized with Rab GTPases involved in fast synaptic vesicles and endosome recycling. Multiple Dominant Negative (DN) Rabs GTPases involved in fast synaptic vesicles or endosome recycling inhibited LC/A1 trafficking to the intracellular plasma membrane and SNAP-25 cleavage. A cytosolic LC/A1 variant that bound the plasma membrane from the cytosol was insensitive to DNRab GTPases involved in fast synaptic vesicle recycling. LC/A1 traffics on fast synaptic vesicles to the intracellular plasma membrane to cleave SNAP-25. Our data suggest, like Heavy Chain host cell entry and LC catalysis, LC intracellular trafficking to target host substrates can contribute to bacterial toxin potency.

Indexed as

Botulinum ToxinsBotulinum Toxins, Type ACell MembraneSynaptic VesiclesSynaptosomal-Associated Protein 25AnimalsHumansMiceProtein TransportBotulinum ToxinsBotulinum Toxins, Type ASynaptosomal-Associated Protein 25

Identifiers

PMID41023315
PMCPMC12480579

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.